Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
27,561
Total Claims
$1.8M
Drug Cost
515
Beneficiaries
$3,470
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-66%
Opioid rate vs peers
0.8% vs 2.2% avg
+146%
Cost per patient vs peers
$3,470 vs $1,411 avg
+17%
Brand preference vs peers
12.4% vs 10.6% avg
Opioid Prescribing
0.8%
Opioid Rate
208
Opioid Claims
$2,973
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 3,404 claims · $1.3M
Generic: 24,069 claims · $518K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Paliperidone Palmitate | 58 | $190K |
| Sitagliptin Phosphate | 628 | $143K |
| Risperidone Microspheres | 40 | $59K |
| Apixaban | 255 | $59K |
| Dulaglutide | 107 | $54K |
| Rivaroxaban | 213 | $50K |
| Linagliptin | 254 | $45K |
| Eslicarbazepine Acetate | 63 | $44K |
| Fluticasone/Vilanterol | 104 | $44K |
| Emtricitabine/Tenofov Alafenam | 16 | $39K |
| Darunavir/Cobicistat | 13 | $35K |
| Chlorpromazine Hcl | 122 | $29K |
| Raltegravir Potassium | 14 | $28K |
| Dolutegravir Sodium | 25 | $27K |
| Insulin Detemir | 77 | $26K |
Prescribing Profile
Patient Profile
61
Avg Age
42%
Female
1.84
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data